Skip to main content
Namita Sood, MD, Pulmonology, Sacramento, CA, UC Davis Medical Center

NamitaSoodMD

Pulmonology Sacramento, CA

Critical Care Medicine, Interstitial Lung Diseases, Pulmonary Vascular Medicine

Professor, Internal Medicine

Dr. Sood is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Sood's full profile

Already have an account?

Summary

  • Dr. Namita Sood is a pulmonologist in Sacramento,CA. She received her medical degree from University of Tripoli School of Medicine and has been in practice 29 years. She specializes in critical care medicine and pleural disease and is experienced in interstitial lung disease, critical care medicine, and pulmonary vascular disease.

Education & Training

  • University of North Carolina Hospitals
    University of North Carolina HospitalsFellowship, Pulmonary Disease and Critical Care Medicine, 1996 - 1999
  • University of Missouri-Columbia
    University of Missouri-ColumbiaResidency, Internal Medicine, 1992 - 1995
  • University of Tripoli School of Medicine
    University of Tripoli School of MedicineClass of 1988

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2020 - 2026
  • TX State Medical License
    TX State Medical License 2016 - 2021
  • OH State Medical License
    OH State Medical License 2001 - 2018
  • NC State Medical License
    NC State Medical License 1996 - 2005
  • American Board of Internal Medicine Critical Care Medicine
  • American Board of Internal Medicine Pulmonary Disease

Awards, Honors, & Recognition

  • Best Physicians in America 2016
  • Excellence in Teaching 2016
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Antithrombotic Therapy for VTE Disease CHEST Guideline and Expert Panel Report  
    Kearon C, Akl E A, Ornelas J, Blaivas A, Jimenez D, Bounameaux H, Huisman M, King C S, Morris T A, Sood N, Stevens S M, Vintch J, Wells P, Woller S C, Moores L, Chest, 1/1/2016
  • Pharmacological Therapy for Pulmonary Arterial Hypertension in Adults CHEST Guidelines  
    Taichman D, Ornelas J, Chung L, Klinger J, Lewis S Z, Mandel J, Palevsky H, Stuart R, Sood N, Trow T, Yung R E C, Badesch D, Chest, 1/1/2014
  • Macitentan for the Treatment of Pulmonary Arterial Hypertension  
    Sood N, Expert Opinion On Pharmacotherapy, 1/1/2014
  • Join now to see all

Abstracts/Posters

  • Results of the Prospective, Multicenter, Single-Arm, Open-Label, Phase 4 MOTION Study of Riociguat in Pulmonary Arterial Hypertension
    SoodN, Aranda A, Platt D, La Rose A, O Brien G, ATS, 1/1/2017
  • Hemodynamic Effects of the Oral Prostacyclin (IP) Receptor Agonist Ralinepag in Pulmonary Arterial Hypertension.
    Sood N, CHEST, 1/1/2017
  • Safety of Ambrisentan in Portopulmonary Hypertension, Result from the AmbrisentaN usaGE in PortopuLmonary Hypertension (ANGEL STUDY)
    Batterjee W, Burger C, Bartolome S,Safdar Z, Kworka M, Sood N,F Hubert, Gromberg-Maitland M, Chakinala M, Hill N, Preston I, ATS, 1/1/2016
  • Join now to see all

Lectures

  • Management of Pulmonary Arterial Hypertension 
    Blanchard Valley Hospital, Findlay, OH, 2008; University of Texas Health Science Center at Houston, - 1/1/2017
  • Special Consideration Regarding Altiltude/ Flying / Diving. 
    University of Texas Health Science Center at Houston - 1/1/2017
  • Case Studies in Pulmonary vascular Disease 
    University of Texas Health Science Center at Houston - 1/1/2017
  • Join now to see all

Press Mentions

  • Reflecting on CHEST 2021
    Reflecting on CHEST 2021November 1st, 2021

Hospital Affiliations